Telmisartan 80mg Non-responder Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 174 participants.
Also called NCT01222520
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 174 participants
- Sponsor
- Registry
-
NCT01222520
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- Not reported
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01222520. Randomized; double masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2011-06 (actual). Results posted on 2012-07-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Telmisartan 80mg Non-responder Trial
- Condition
- Hypertension
- Intervention (Drug)
- Telmisartan and amlodipine
- Intervention (Drug)
- Telmisartan
- Lead sponsor
- Boehringer Ingelheim
Record details
- Record id
cardio:ct-nct01222520- Content hash
2edfd434ad6959e59c94d4d08a5b14d68d208fb531fa0325c035113348275d21